Home » Topics » BioWorld Science

BioWorld Science
RSS

AAV encoding NUsc1 rescues memory in Alzheimer's disease model

Nov. 8, 2019

Novel gene therapy for the treatment of Alzheimer's disease

Nov. 8, 2019

Merck KGaA starts phase III study of L-praziquantel orodispersible in Schistosoma-infected children

Nov. 8, 2019

Recombinant human thrombomodulin evaluated for ARDS with disseminated intravascular coagulation

Nov. 8, 2019

Psioxus Therapeutics presents series of oncolytic viral compounds for cancer

Nov. 8, 2019

Novel nonhuman primate model of induced colitis

Nov. 8, 2019

Antisense therapy with antagomiR-23b shows promise for the treatment of DM1

Nov. 8, 2019

Discovery and preclinical characterization of a novel anti-CD178 antibody, FBP-002

Nov. 8, 2019

Voclosporin DDI study demonstrates no clinically significant interaction with MMF

Nov. 8, 2019

Positive topline data from phase III VANISH-303 registration study of oral ibrexafungerp

Nov. 8, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...